https://scholars.lib.ntu.edu.tw/handle/123456789/551903
Title: | Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort | Authors: | SHENG-KAI LIANG LI-TA KENG CHIA-HAO CHANG Wen, Yueh-Feng MENG-RUI LEE CHING-YAO YANG JANN-YUAN WANG JEN-CHUNG KO JIN-YUAN SHIH CHONG-JEN YU |
Issue Date: | 2021 | Publisher: | Frontiers Media S.A. | Journal Volume: | 10 | Start page/Pages: | 590356 | Source: | Frontiers in Oncology | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85099742333&doi=10.3389%2ffonc.2020.590356&partnerID=40&md5=b81f9bc6241932c9450909e70654077c https://scholars.lib.ntu.edu.tw/handle/123456789/551903 |
ISSN: | 2234-943X | DOI: | 10.3389/fonc.2020.590356 |
Appears in Collections: | 醫學系 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.